Is Revolution Medicines, Inc. (RVMD) a Buy, Sell, or Hold?
NASDAQ : RVMD
Revolution Medicines, Inc. — Stock Grades
$189.23 USD
$0.48 (0.25%)
- Volume
- 1.29M
- Average Volume
- 2.84M
- Market Capitalization
- $40.23B
- P/E Ratio
- -26.61
- Dividend Yield
- 0.00%
- Price Target
- $195.00
- Year High
- $193.83
- Year Low
- $34.00
- Day High
- —
- Day Low
- —
- Payout Ratio
- $0.00
- Current Ratio
- $6.80
RVMD Stock Grades
| Date | Grading Company | Previous Grade | New Grade | Action |
|---|---|---|---|---|
| 2026-07-23 | Wedbush | Outperform | Outperform | Maintain |
| 2026-07-20 | Needham | Buy | Buy | Maintain |
| 2026-07-09 | Guggenheim | Buy | Buy | Maintain |
| 2026-07-06 | HC Wainwright & Co. | Buy | Buy | Maintain |
| 2026-07-06 | Mizuho | Outperform | Outperform | Maintain |
| 2026-07-02 | Wedbush | Outperform | Outperform | Maintain |
| 2026-06-30 | Truist Securities | Buy | Buy | Maintain |
| 2026-06-29 | Needham | Buy | Buy | Maintain |
| 2026-06-10 | Evercore ISI Group | Outperform | Outperform | Maintain |
| 2026-06-02 | RBC Capital | Outperform | Outperform | Maintain |
| 2026-06-01 | HC Wainwright & Co. | Buy | Buy | Maintain |
| 2026-06-01 | Oppenheimer | Outperform | Outperform | Maintain |
| 2026-05-07 | Wedbush | Outperform | Outperform | Maintain |
| 2026-05-07 | Piper Sandler | Overweight | Overweight | Maintain |
| 2026-05-07 | Needham | Buy | Buy | Maintain |
| 2026-05-07 | RBC Capital | Outperform | Outperform | Maintain |
| 2026-05-07 | Guggenheim | Buy | Buy | Maintain |
| 2026-04-22 | HC Wainwright & Co. | Buy | Buy | Maintain |
| 2026-04-22 | Leerink Partners | Outperform | Outperform | Maintain |
| 2026-04-20 | Stifel | Buy | Buy | Maintain |
| 2026-04-20 | Needham | Buy | Buy | Maintain |
| 2026-04-14 | Evercore ISI Group | Outperform | Outperform | Maintain |
| 2026-04-14 | Wedbush | Outperform | Outperform | Maintain |
| 2026-04-14 | Wells Fargo | Overweight | Overweight | Maintain |
| 2026-04-14 | RBC Capital | Outperform | Outperform | Maintain |
| 2026-04-14 | HC Wainwright & Co. | Buy | Buy | Maintain |
| 2026-04-14 | Guggenheim | Buy | Buy | Maintain |
| 2026-04-13 | Oppenheimer | Outperform | Outperform | Maintain |
| 2026-04-13 | Leerink Partners | Outperform | Outperform | Maintain |
| 2026-02-26 | Wells Fargo | Overweight | Overweight | Maintain |
| 2026-02-26 | Piper Sandler | Overweight | Overweight | Maintain |
| 2026-02-26 | Needham | Buy | Buy | Maintain |
| 2026-02-02 | JP Morgan | Overweight | Overweight | Maintain |
| 2026-01-27 | Oppenheimer | Outperform | Outperform | Maintain |
| 2026-01-22 | Stifel | Buy | Buy | Maintain |
| 2026-01-21 | RBC Capital | Outperform | Outperform | Maintain |
| 2026-01-20 | Guggenheim | Buy | Buy | Maintain |
| 2026-01-13 | Mizuho | Outperform | Outperform | Maintain |
| 2026-01-09 | Wedbush | Outperform | Outperform | Maintain |